NSE : Sun Pharma Advanced Research Company Ltd

Name
Last
470.75
3.05 (0.64%)
Market sentiment for SPARC
Month
43%57%
Low - High
448.55 - 485.90
Open - Prev Close
480.00 - 473.80
52W Low - High
143.75 - 598.00
P/E Ratio
442.80
P/B Ratio
82.54
EPS (Rs.)
1.10
Mkt Cap (cr)
11,529.70
Shares Traded
15,96,670
Date
News
04 Mar
Sun Pharma Advanced Research Company Limited - Press Release

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated March 03, 2015, titled "SPARC announces USFDA approval of ELEPSIA XR (Levetiracetam) extended-release tablets 1000 mg and 1500 mg".
16 Jan
Sun Pharma Advanced Research Company Limited - Trading Window
02 Dec
Sun Pharma Advanced Research Company Limited - Press Release
28 Nov
Sun Pharma Advanced Research Company Limited - Conversion
21 Nov
Sun Pharma Advanced Research Company Limited - Updates
20 Mar
MMF Solutions Daily Stock
02 Mar
Buy SPARC target of Rs 432
27 Feb
SUN PHARMA 866 Sell considering 874 884 crucial resistances keeping stop loss of 894
26 Feb
RANBAXY 688 Sell considering 694 698 crucial resistances keeping stop loss of 706.
Key Financials
Latest Qrtr.
Trailing Yr.
Full Yr.
Year End
Dec, 2014
Dec, 2014
Mar, 2014
Sales (Rs.cr)
31.28
155.61
167.03
Net Profit (Rs.cr)
-18.91
-36.70
26.25
EPS (Rs)
-
-
1.10
P/E Ratio
-
-
442.80
Operating Profit Margin
-
-20.78
-
CPS (Rs.)
-
-
1.30
P/C Ratio
-
-
386.60


Get live Sun Pharma Advanced Research Company share price on nse india. Get quote on Sun Pharma Advanced Research Company current share market price, free share tips, news, announcements & key financials

© appuonline Updated : March 27 03:42 PM